Does Cosentyx (secukinumab) interact with Mounjaro (tirzepatide)?
No direct drug–drug interaction between Cosentyx and Mounjaro is known from the information available here. Cosentyx is a biologic (secukinumab) given by injection that works by targeting interleukin-17A, while Mounjaro (tirzepatide) is a separate medication used for type 2 diabetes and works through GLP-1/GIP pathways. There is no common interaction mechanism (like shared metabolism through a single liver enzyme) that would typically predict a clinically significant interaction between these two drugs.
Does Cosentyx interact with temazepam (Tamazepam)?
No direct drug–drug interaction between Cosentyx and temazepam is known from the information available here. Temazepam is a benzodiazepine used for anxiety/insomnia, and Cosentyx’s mechanism is immunologic (IL-17A blockade). With no shared metabolic pathway signaling or known interaction mechanism, a clinically meaningful interaction is not expected.
Are there still practical reasons patients might notice issues when combining them?
Even when a formal drug–drug interaction isn’t expected, clinicians may still pay attention to:
- Infection risk: Cosentyx can increase susceptibility to certain infections. If temazepam or Mounjaro side effects (like fatigue, nausea, or sedation) affect sleep, hydration, or ability to monitor symptoms, infections might be noticed later.
- Symptom overlap: Mounjaro can cause gastrointestinal side effects, and Cosentyx can be associated with some systemic symptoms in certain patients. Tracking what started when can help distinguish causes.
What to do next if you want a definitive check for your exact situation?
The most reliable answer comes from a clinician-pharmacist medication review using your full list (including over-the-counter meds, supplements, and any other immunosuppressants). If you share your dose(s) and how long you’ve been taking each drug, I can help you format what to ask and what to look for.